Kalos Management’s Takeda Pharmaceutical TAK Stock Holding History

Kalos Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-127,540	Closed	-$2.09M	–	313
2021 Q2	$2.09M	Sell	127,540 -5,648	-4%	-$96.1K	0.85%	27
2021 Q1	$2.23M	Buy	133,188 +45,074	+51%	+$811K	0.69%	26
2020 Q4	$1.56M	Sell	88,114 -4,795	-5%	-$84.1K	0.67%	48
2020 Q3	$1.59M	Sell	92,909 -12,011	-11%	-$219K	0.71%	45
2020 Q2	$1.94M	Sell	104,920 -12,281	-10%	-$220K	0.82%	45
2020 Q1	$2.06M	Sell	117,201 -11,960	-9%	-$217K	0.92%	32
2019 Q4	$2.55M	Buy	+129,161	New	+$2.47M	0.93%	30

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kalos Management's TAK Position: Q3 2021 in Review

Kalos Management sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 127,540 shares — an estimated $2.09M sold.

Kalos Management first reported a position in TAK in Q4 2019 and held it in 7 quarters. The position peaked at $2.55M in Q4 2019. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

Kalos Management reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Kalos Management sold 127,540 Takeda Pharmaceutical shares in Q3 2021, an estimated $2.09M.
Kalos Management first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 7 quarters.
Kalos Management's Takeda Pharmaceutical position peaked at $2.55M in Q4 2019.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Kalos Management's 13F filing for Q3 2021, filed 10 Nov 2021.